Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites

Juan Carlos Bazo-Alvarez1, Renato Quispe, Frank Peralta

  • 1From the *CRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru; †Santa Cruz de Ratacocha Primary Healthcare Centre, Social Service in Rural Setting, Ministry of Health, Huanuco, Peru; ‡Division of Cardiology, Department of Medicine, §Duke Clinical Research Institute, ¶Duke Global Health Institute, Duke University, Durham, NC; ‖School of Medicine, University College London, London, UK; **Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ††Asociación Benéfica PRISMA, Lima, Peru; ‡‡Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, MD; §§Department of Medicine, School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; and ¶¶Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

Insights

Cardiovascular disease (CVD) risk scores show poor agreement in Peruvian populations. Current tools lack reliability for public health interventions in low- and middle-income countries, necessitating improved risk assessment strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) risk prediction accuracy in low- and middle-income countries (LMICs) is uncertain.
  • Existing CVD risk scores may not be suitable for diverse global populations.

Purpose of the Study:

  • To compare the performance of the American College of Cardiology/American Heart Association (ACC/AHA) Pooled Cohort risk equations against six other CVD risk tools.
  • To assess the concordance of predicted CVD risk using various tools in Peruvian populations.

Main Methods:

  • Utilized data from two Peruvian population-based studies across five geographical sites.
  • Compared the ACC/AHA model with Framingham (lab and non-lab), Reynolds, Systematic Coronary Risk Evaluation, WHO, and Lancet risk charts.
  • Employed Lin's concordance correlation coefficient to measure agreement in predicted CVD risk.

Main Results:

  • Analyzed data from 2,183 subjects (mean age 54.3 years).
  • Found poor agreement between the ACC/AHA model and other compared CVD risk scores.
  • The ACC/AHA model identified a higher proportion of individuals at high 10-year CVD risk (29.0%) compared to WHO risk charts (0.6%).

Conclusions:

  • The poor concordance among CVD risk scores highlights uncertainty in their application for public health and clinical decisions in Latin America.
  • There is a critical need for developing and validating CVD risk scores specifically for LMICs.
  • Current risk assessment tools require improvement to accurately predict CVD risk in diverse, underrepresented populations.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
879
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.6K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861